85-1778-63　SB202190 (FHPI, 4-(4-Fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)-1H-imidazole) 25mg　CAS No:152121-30-7　045271

特徴

• Potent and cell permeable p38 MAP kinase inhibitor. Apoptosis inducer. Inhibits p38alpha and beta, but not gamma and delta isoforms. Does not inhibit ERK2 or other members of the MAP kinase family or their upstream activators. JNK activator.
• Synonyms:FHPI; 4-(4-Fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)-1H-imidazole
• Molecular Weight:331.3
• Molecular Formula:C20H14FN3O
• Solubility:Methanol, DMSO or acetone; slightly soluble in ethyl acetate.
• Appearance:Supplied as an off-white solid.
• Purity:≥97% (HPLC)
• Storage and Stability:Store at 4°C. Caution: Light-sensitive. For maximum recovery of product, centrifuge the original vial prior to removing the cap.

仕様

• Size：25mg
• Grade：Highly Purified
• Purity：≥97% (HPLC)
• Form：Supplied as an off-white solid.
• Molecular Formula：C20H14FN3O
• Molecular Weight Non Ab：331.3
• EU Commodity Code：38220090
• この商品は法規制を確認しておりません。(法規制によって販売できない場合もございます)
• 製品の仕様は予告なく変更になる場合がございます。最新仕様はメーカーホームページをご確認ください。
• CAS No ：152121-30-7

• 【試薬に関するお問合せ】
• アズワン株式会社 試薬・プロセス材料グループ
• TEL：06-6447-8641
• FAX：06-6447-8642
• E-mail：[email protected]